Login Register Cart 0
Generic placeholder image

Current Nanomedicine

Editor-in-Chief

ISSN (Print): 2468-1873
ISSN (Online): 2468-1881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Cancer Nano-therapeutics: Prospective and Challenges

Author(s): Mahfoozur Rahman, Sohail Akhter and Sarwar Beg

Volume 10, Issue 2, 2020

Page: [88 - 89] Pages: 2

DOI: 10.2174/246818731002200713102715

« Previous
[1]
Akhter S, Ahmad I, Ahmad MZ, et al. Nanomedicines as cancer therapeutics: current status. Current cancer drug targets 2013; 13(4): 362-78.
[2]
Rahman M, Ahmad MZ, Kazmi I, et al. Emergence of nanomedicine as cancer targeted magic bullets: Recent development and need to address the toxicity apprehension. Current drug discovery technologies 2012; 9(4): 319-29.
[3]
Akhter S, Ahmad Z, Singh A, et al. Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern. Current pharmaceutical design, 2011; 17(18): 1834-50.
[4]
Rahman M, Akhter S, Ahmad MZ, et al. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges. Nanomedicine 2015; 10(15): 2405-22.
[5]
Ahmad J, Akhter S, Greig NH, Kamal MA, Midoux P, Pichon C. Engineered nanoparticles against MDR in Cancer: the state of the art and its prospective. Current pharmaceutical design 2016; 22(28): 4360-73.
[6]
Rahman M, Beg S, Verma A, et al. Therapeutic applications of liposomal based drug delivery and drug targeting for immune linked inflammatory maladies: A contemporary view point. Curr Drug Targets 2017 Apr 14.
[http://dx.doi.org/10.2174/1389450118666170414113926]
[7]
Beg S, Rahman M, Jain A, et al. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications. Drug Discov Today 2017; 22(4): 625-37.
[8]
Rahman M, Kumar V, Beg S, Sharma G, Katare OP, Anwar F. Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art. Artif Cells Nanomed Biotechnol 2016 Nov; 44(7): 1597-608.
[9]
Ahmad J, Akhter S, Rizwanullah M, et al. Nanotechnology-based inhalation treatments for lung cancer: state of the art. Nanotechnol Sci Appl 2015 Nov 19; 8: 55-66.
[10]
Ahmad J, Amin S, Rahman M, et al. Solid Matrix Based Lipidic Nanoparticles in Oral Cancer Chemotherapy: Applications and Pharmacokinetics. Curr Drug Metab 2015; 16(8): 633-44.
[11]
Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges. Rahman M, Akhter S, Ahmad MZ, Ahmad J, Addo RT, Ahmad FJ, Pichon C. Nanomedicine (Lond) 2015; 10(15): 2405-22.
[12]
Cancer targeted magic bullets for effective treatment of cancer. Aneja P, Rahman M, Beg S, Aneja S, Dhingra V, Chugh R. Recent Pat Antiinfect Drug Discov 2014; 9(2): 121-35.
[13]
Role of Graphene Nano-Composites in Cancer Therapy: Theranostic Applications, Metabolic Fate and Toxicity Issues. Rahman M, Ahmad MZ, Ahmad J, Firdous J, Ahmad FJ, Mushtaq G, Kamal MA, Akhter S. Curr Drug Metab 2015; 16(5): 397-409.
[14]
Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation. Ahmad MZ, Akhter S, Anwar M, Kumar A, Rahman M, Talasaz AH, Ahmad FJ. Drug Dev Ind Pharm 2013 Dec; 39(12): 1936-43.
[15]
Advancement in multifunctional nanoparticles for the effective treatment of cancer. Rahman M, Ahmad MZ, Kazmi I, Akhter S, Afzal M, Gupta G, Jalees Ahmed F, Anwar F. Expert Opin Drug Deliv 2012 Apr; 9(4): 367-81.
[16]
Development of polysaccharide based colon targeted drug delivery system: design and evaluation of Assam Bora rice starch based matrix tablet. Ahmad MZ, Akhter S, Ahmad I, Rahman M, Anwar M, Jain GK, Ahmad FJ, Khar RK. Curr Drug Deliv 2011 Sep; 8(5): 575-81.
[17]
Metallic nanoparticles: technology overview & drug delivery applications in oncology. Ahmad MZ, Akhter S, Jain GK, Rahman M, Pathan SA, Ahmad FJ, Khar RK. Expert Opin Drug Deliv 2010 Aug; 7(8): 927-42.
[18]
Rahman M, Beg S, Ahmed A, and Swain S. Emergence of functionalized nanomedicines in cancer chemotherapy: recent advancements, current challenges and toxicity considerations. Recent Patent on Nanomedicine 2013; 2: 128-39.
[19]
Rahman M, Ahmed MZ, Kazmi I, et al. Novel approach for the treatment of cancer: Theranostic nanomedicines. Pharmacologia 2012; 3: 371-6.
[20]
Kumar V, Bhatt PC, Rahman M, et al. Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies. Int J Nanomedicine 2017; 12: 6747-58.

Rights & Permissions Print Cite
Article Metrics
28
1
© 2024 Bentham Science Publishers | Privacy Policy